AstraZeneca will lay off 94 workers from its campus in the United Kingdom by 2020, according to online publication in-Pharmatechnologist.
AstraZeneca said the job cuts are a result of increased efficiencies following a multimillion-dollar upgrade at its plant in Macclesfield. Now, fewer employees are needed to maintain operations.
GMB Union, a local union representing the U.K. workers, called the decision a "hammer blow for manufacturing," according to the report.
The campus in the U.K. where the job cuts will occur produces small-molecule drugs.